- 學位論文
尋找人類組蛋白去甲基酶KDM4抑制劑並加以修飾進而應用在治療去勢抗性前列腺癌
Discovery and Modification of KDM4 Inhibitors in Castration-Resistant Prostate Cancer Treatment
延伸閱讀
- Lin, T. Y. (2018). 人類組蛋白去甲基酵素KDM4B在抗去勢前列腺癌之代謝適應上扮演關鍵的角色 [master's thesis, National Tsing Hua University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0016-1803201914471465
- Ming, W. C. (2015). 人類組蛋白去甲基酵素KDM4B之天然抑制劑開發 [master's thesis, National Tsing Hua University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0016-0312201510242453
- Tien, F. M. (2018). 去甲基化藥物對於急性骨髓性白血病治療的有效性與調控機轉 [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201804065
- Liaw, Y. M., & Kuo, H. C. (2006). 合併藥物治療良性前列腺肥大病人後停止甲型腎上腺素交感神經抑制劑或5α-還原酶抑制劑之研究. 慈濟醫學雜誌, 18(2), 91-96. https://doi.org/10.6440/TZUCMJ.200604.0091
- 侯佩伸（2017）。Molecular mechanisms of AMPK mediated docetaxel-resistance in human prostate cancer〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2808201721021800